Photo of Wei-Chiao Chang

View Scopus Profile

Wei-Chiao Chang

Professor

 https://orcid.org/0000-0002-8573-5924
  • 2428 Citations
  • 24 h-Index
20022021

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2007 DPhil (Physiology and Genomics), University of Oxford
  • 2001 M.S., Department of Pharmacology, National Cheng Kung University
  • 1999 B.S., School of Pharmacy, Taipei Medical University

Experience

  • 2018.05- Professor, Master Program in Applied Molecular Epidemiology, Taipei Medical University
  • 2018.01- Deputy Superintendent, College of Pharmacy, Taipei Medical University
  • 2015.08- Professor, Department of Clinical Pharmacy, Taipei Medical University
  • 2012.08-2015.07 Associate Professor, School of Pharmacy, Taipei Medical University
  • 2015.08- Associate Professor, Ph.D Program for Translational Medicine, Taipei Medical University
  • 2013.08- Associate Professor, Ph.D Program for Clinical Drug Discovery from Botanical Herbs, Taipei Medical University
  • 2013.08-2019.07 Director, Ph.D Program for Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
  • 2013.08- Associate Professor, Ph.D Program for Neural Regenerative Medicine, Taipei Medical University
  • 2012.10-2013.07 Director, Ph.D Program for Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
  • 2012.08- Ph.D Program for Neural Regenerative Medicine, Taipei Medical University
  • 2016.04-2017.04 Secretary General, The Pharmaceutical Society of Taiwan
  • 2009.02-2012.07 Assistant Professor, Kaohsiung Medical University
  • 2002.09-2003.10 Deputy Administrator, Food and Drug Administration of Taiwan

Research Interests

  • Genetic characterization of calcium channel related genes to establish personalized therapy
  • Molecular identification for human genetic variants and drug responses

Awards

  • 2019 Research Dissertation Award - Excellence Award, Taipei Medical University

Fingerprint Dive into the research topics where Wei-Chiao Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

2-1-3 精進核心研究服務平台-胃腸道腫瘤精準醫療奈米與免疫指標暨療法開發

Chang, W.

1/1/20 → 12/31/20

Project: A - Government Institution › d - Ministry of Education

研究計畫補助費-延攬博士後獎勵補助(張偉嶠)

Chang, W.

10/1/19 → 10/1/21

Project: B - Project of TMU › h - Other (Funded by TMU)

進展性胰臟癌新穎增進免疫療法的治療策略與生物指標－對免疫療法併用方案節拍式化療或射頻燒灼療法之胰臟癌患者進行基因標記和免疫基因組庫之鑑定與分析(1/3)相對補助

Chang, W.

8/1/19 → 7/31/20

Project: A - Government Institution › f - Other (Funded by Government)

Identification of Genomic Markers and Immune Repertoires for Combinations of Immunotherapy with Metronomic Chemotherapy or Radiofrequency Thermal Ablation in Pancreatic Ductal Adenocarcinoma( I )

Chang, W.

8/1/19 → 7/31/20

Project: A - Government Institution › b - Ministry of Science and Technology

以高通量定序發展免疫基因體學：研究T-細胞基因組庫(repertoire)多樣性及克隆型(clonal selection )與大腸直腸癌之相關性(4/4)

Chang, W.

5/1/19 → 7/31/20

Project: A - Government Institution › b - Ministry of Science and Technology

Research Output

CLEC5A: A Promiscuous Pattern Recognition Receptor to Microbes and Beyond

Sung, P. S., Chang, W. C. & Hsieh, S. L., Jan 1 2020, Advances in Experimental Medicine and Biology. Springer India, p. 57-73 17 p. (Advances in Experimental Medicine and Biology; vol. 1204).

Research output: Chapter in Book/Report/Conference proceeding › Chapter

    • 1 Citation (Scopus)

    HSPB1 rs2070804 polymorphism is associated with the depth of primary tumor

    Hung, C. S., Huang, C. Y., Hsu, Y. W., Makondi, P. T., Chang, W. C., Chang, Y. J., Wang, J. Y. & Wei, P. L., Jan 1 2020, In : Journal of Cellular Biochemistry. 121, 1, p. 63-69 7 p.

    Research output: Contribution to journal › Article

    • Quantitative determination of human IgA subclasses and their Fc-glycosylation patterns in plasma by using a peptide analogue internal standard and ultra-high-performance liquid chromatography/triple quadrupole mass spectrometry

    Chen, H. F., Shiao, C. Y., Wu, M. Y., Lin, Y. C., Chen, H. H., Chang, W. C., Wu, M. S., Kao, C. C. & Tsai, I. L., Apr 1 2020, (Accepted/In press) In : Rapid Communications in Mass Spectrometry. 34, S1

    Research output: Contribution to journal › Article

    • Association of endothelin genetic variants and hospitalized infection complications in end-stage renal disease (ESRD) patients

    Kao, C. C., Cheng, S. Y., Wang, Y. J., Chien, S. C., Hsu, Y. W., Wu, M. Y., Lu, H. F., Nam, S., Sun, T., Wu, M. S. & Chang, W. C., Jun 5 2019, In : BMC Nephrology. 20, 1, p. 203 203.

    Research output: Contribution to journal › Article

    Open Access

    • Cancers in Taiwan: Practical insight from epidemiology, treatments, biomarkers, and cost

    Kuo, C. N., Liao, Y. M., Kuo, L. N., Tsai, H. J., Chang, W. C. & Yen, Y., Jan 1 2019, (Accepted/In press) In : Journal of the Formosan Medical Association.

    Research output: Contribution to journal › Review article

    Open Access
    • 3 Citations (Scopus)